Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

VCEL

Vericel Corp

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 887359Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$276.0M
Net Income FY2025
$17.0M
EPS (Basic, as reported)
$0.33
Net Margin FY2025
6.0%
ROE FY2025
4.7%
Total Equity
$355.0M
Shares Out
51M
Business description

Vericel Corp — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 54 → 276 +19.9% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue546391118122153164198237276
Cost of revenue(28)(30)(32)(38)(40)(50)(55)(62)(65)(71)
Gross profit2634598084106110136172206
Research & development(15)(13)(14)(30)(13)(16)(20)(21)(25)(28)
Selling, general & administrative(27)(36)(49)(61)(69)(98)(107)(121)(143)(167)
Selling & marketing——————(61)(69)(82)(90)
General & administrative——————(46)(52)(61)(77)
Total operating expenses(45)(49)(63)(92)(82)(114)(127)(142)(168)(195)
Operating income(19)(15)(4)(11)2(8)(17)(6)511
Interest expense0(1)00000(1)(1)(1)
Interest & investment income0012101567
Other income (expense), net0(2)(4)2101466
Pre-tax income(20)(17)(8)(10)3(8)(16)(2)1117
Income tax expense000000(1)(1)0(1)
Net income(20)(17)(8)(10)3(7)(17)(3)1017
EPS — basic——($0.20)($0.22)$0.06($0.16)($0.35)($0.07)$0.21$0.33
EPS — diluted——($0.20)($0.22)$0.06($0.16)($0.35)($0.07)$0.20$0.32
Shares outstanding — basic (M)——4044454647484950
Shares outstanding — diluted (M)——4044474647485252

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.